These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 1531061

  • 1. Expression of interferon-gamma receptors in normal and psoriatic skin.
    Scheynius A, Fransson J, Johansson C, Hammar H, Baker B, Fry L, Valdimarsson H.
    J Invest Dermatol; 1992 Feb; 98(2):255-8. PubMed ID: 1531061
    [Abstract] [Full Text] [Related]

  • 2. Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions.
    Nickoloff BJ, Mitra RS, Elder JT, Fisher GJ, Voorhees JJ.
    Br J Dermatol; 1989 Aug; 121(2):161-74. PubMed ID: 2476168
    [Abstract] [Full Text] [Related]

  • 3. Proliferation and interferon-gamma receptor expression in psoriatic and healthy keratinocytes are influenced by interactions between keratinocytes and fibroblasts in a skin equivalent model.
    Fransson J, Emilson A, Scheynius A, Hammar H.
    Arch Dermatol Res; 1995 Aug; 287(6):517-23. PubMed ID: 7487135
    [Abstract] [Full Text] [Related]

  • 4. An altered response by psoriatic keratinocytes to gamma interferon.
    Baker BS, Powles AV, Valdimarsson H, Fry L.
    Scand J Immunol; 1988 Dec; 28(6):735-40. PubMed ID: 3148190
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Distribution of interferon-gamma receptors in normal and psoriatic skin.
    van den Oord JJ, De Ley M, De Wolf-Peeters C.
    Pathol Res Pract; 1995 Jul; 191(6):530-4. PubMed ID: 7479374
    [Abstract] [Full Text] [Related]

  • 7. Regulation of involucrin in psoriatic epidermal keratinocytes: the roles of ERK1/2 and GSK-3β.
    Chen JQ, Man XY, Li W, Zhou J, Landeck L, Cai SQ, Zheng M.
    Cell Biochem Biophys; 2013 Jul; 66(3):523-8. PubMed ID: 23283814
    [Abstract] [Full Text] [Related]

  • 8. Immunohistopathologic studies in the development of psoriatic lesion influenced by gamma-interferon and the producing cells.
    Kaneko F, Suzuki M, Takiguchi Y, Itoh N, Minagawa T.
    J Dermatol Sci; 1990 Nov; 1(6):425-34. PubMed ID: 2126953
    [Abstract] [Full Text] [Related]

  • 9. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
    van der Fits L, van der Wel LI, Laman JD, Prens EP, Verschuren MC.
    J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
    Piskin G, Sylva-Steenland RM, Bos JD, Teunissen MB.
    J Immunol; 2006 Feb 01; 176(3):1908-15. PubMed ID: 16424222
    [Abstract] [Full Text] [Related]

  • 11. Psoriatic keratinocytes show reduced IRF-1 and STAT-1alpha activation in response to gamma-IFN.
    Jackson M, Howie SE, Weller R, Sabin E, Hunter JA, McKenzie RC.
    FASEB J; 1999 Mar 01; 13(3):495-502. PubMed ID: 10064616
    [Abstract] [Full Text] [Related]

  • 12. Keratinocyte CDw60 expression is modulated by both a Th-1 type cytokine IFN-gamma and Th-2 cytokines IL-4 and IL-13: relevance to psoriasis.
    Huang BB, Bonish BK, Chaturvedi V, Qin JZ, Nickoloff BJ.
    J Invest Dermatol; 2001 Feb 01; 116(2):305-12. PubMed ID: 11180008
    [Abstract] [Full Text] [Related]

  • 13. IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production.
    Wei L, Debets R, Hegmans JJ, Benner R, Prens EP.
    J Pathol; 1999 Feb 01; 187(3):358-64. PubMed ID: 10398092
    [Abstract] [Full Text] [Related]

  • 14. Response of keratinocytes from normal and psoriatic epidermis to interferon-gamma differs in the expression of zinc-alpha(2)-glycoprotein and cathepsin D.
    Chen SH, Arany I, Apisarnthanarax N, Rajaraman S, Tyring SK, Horikoshi T, Brysk H, Brysk MM.
    FASEB J; 2000 Mar 01; 14(3):565-71. PubMed ID: 10698972
    [Abstract] [Full Text] [Related]

  • 15. Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin.
    Milde P, Hauser U, Simon T, Mall G, Ernst V, Haussler MR, Frosch P, Rauterberg EW.
    J Invest Dermatol; 1991 Aug 01; 97(2):230-9. PubMed ID: 1649228
    [Abstract] [Full Text] [Related]

  • 16. In situ localization of interferons in psoriatic lesions.
    Livden JK, Nilsen R, Bjerke JR, Matre R.
    Arch Dermatol Res; 1989 Aug 01; 281(6):392-7. PubMed ID: 2480752
    [Abstract] [Full Text] [Related]

  • 17. Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets.
    Szabo SK, Hammerberg C, Yoshida Y, Bata-Csorgo Z, Cooper KD.
    J Invest Dermatol; 1998 Dec 01; 111(6):1072-8. PubMed ID: 9856819
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells.
    Bonish B, Jullien D, Dutronc Y, Huang BB, Modlin R, Spada FM, Porcelli SA, Nickoloff BJ.
    J Immunol; 2000 Oct 01; 165(7):4076-85. PubMed ID: 11034419
    [Abstract] [Full Text] [Related]

  • 19. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol).
    Fukuoka M, Ogino Y, Sato H, Ohta T, Komoriya K, Nishioka K, Katayama I.
    Br J Dermatol; 1998 Jan 01; 138(1):63-70. PubMed ID: 9536224
    [Abstract] [Full Text] [Related]

  • 20. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
    Gottlieb AB, Lifshitz B, Fu SM, Staiano-Coico L, Wang CY, Carter DM.
    J Exp Med; 1986 Oct 01; 164(4):1013-28. PubMed ID: 2428913
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.